Gene of the month: Cornulin

2021 ◽  
pp. jclinpath-2021-208011
Author(s):  
Rajandeep Kaur ◽  
Anshika Chauhan ◽  
Shabir Ahmad Bhat ◽  
Debajyoti Chatterjee ◽  
Sushmita Ghoshal ◽  
...  

Cornulin (CRNN) gene encodes a 495 amino acid long protein and is located on chromosome 1q21.3. Primarily, it functions as the marker of differentiation. Initially, it was found to be specific for the squamous cells of oesophagus. However, later on, several studies have revealed the presence of Cornulin downregulation in various epithelial squamous cell carcinomas of the head and neck, oesophagus and cervix and clinically associated it with worsening of cancer and the poor prognosis. Cornulin levels also showed dysregulation in other diseases such as Eczema and Psoriasis. Besides the differentiation marker, it was identified to be involved in the stress response. The studies, in psoriasis and oesophageal squamous cell carcinoma, has elucidated that the dysregulation in the Cornulin is associated with the cell cycle events such as G1/S transition. However, the actual function of Cornulin is still yet to be explored in detail.

2014 ◽  
Vol 66 (2) ◽  
pp. 192-200 ◽  
Author(s):  
Xinwen Zhong ◽  
Xiaolong Chen ◽  
Xiaojiao Guan ◽  
Heng Zhang ◽  
Yinan Ma ◽  
...  

2021 ◽  
Vol 41 (2) ◽  
pp. 783-794
Author(s):  
MASAZUMI INOUE ◽  
HIROYA TAKEUCHI ◽  
SACHIKO MATSUDA ◽  
TOMOHIKO NISHI ◽  
KAZUMASA FUKUDA ◽  
...  

2016 ◽  
Vol 115 (1) ◽  
pp. 66-75 ◽  
Author(s):  
Hisashi Hara ◽  
Tsuyoshi Takahashi ◽  
Satoshi Serada ◽  
Minoru Fujimoto ◽  
Tomoharu Ohkawara ◽  
...  

2019 ◽  
Author(s):  
Xiaoting He ◽  
Suqing Li ◽  
Weihong Shi ◽  
Qingfeng Lin ◽  
Jian Ma ◽  
...  

2013 ◽  
Vol 30 (6) ◽  
pp. 2625-2631 ◽  
Author(s):  
MICHITAKA KIMURA ◽  
HIROSHI NAITO ◽  
TAKASHI TOJO ◽  
ASAKO ITAYA-HIRONAKA ◽  
YOSHIKO DOHI ◽  
...  

1989 ◽  
Vol 42 (4) ◽  
pp. 229-233 ◽  
Author(s):  
Hiroyuki Kuwano ◽  
Hideo Baba ◽  
Hiroyuki Matsuda ◽  
Shinji Ohno ◽  
Masaki Mori ◽  
...  

2021 ◽  
Vol 20 ◽  
pp. 153473542110621
Author(s):  
Guiping Liu ◽  
Tao Zeng

Tumor metastasis is a key factor of therapeutic failure in tumor patients, but the underlying molecular mechanism remains to be explored and novel effective curative strategies are urgently required. Emerging evidence suggests that sporoderm-removed Ganoderma lucidum spore powder can suppress tumor growth and metastasis. However, the molecular mechanisms of action remain elusive. In the present study, we investigated the effects and mechanisms of sporoderm-removed Ganoderma lucidum spore powder against esophageal squamous cell carcinomas (ESCC). The expression of MCP-1 in esophageal squamous cell carcinoma cells was detected by Western blotting. The MTS assay was used to assess the esophageal squamous cell carcinoma cells viability. The clone formation assay was used to evaluate to the proliferation ability of KYSE140 and KYSE510 cells. Apoptosis and the cell cycle were analyzed by flow cytometry. Wound healing and Transwell assays were used to analyze the migration of KYSE140 and KYSE510 cells. Invasion was also analyzed by the Transwell assay. The expressions of PI3K, AKT/p-AKT, Erk/p-Erk, JNK1, and mTOR were detected by Western blotting. We found that the MCP-1 protein was highly expressed in KYSE140 and KYSE510. In addition, sporoderm-removed Ganoderma lucidum spore powder treatment was found to inhibit esophageal squamous cell carcinoma cell proliferation, to block the cell cycle, to induce cell apoptosis and to inhibit cell migration and invasion. Finally, we found that sporoderm-removed Ganoderma lucidum spore powder decreased the expression of PI3K/AKT/mTOR and Erk signaling pathways. Taken together, these findings demonstrate that sporoderm-removed Ganoderma lucidum spore powder suppresses esophageal squamous cell carcinomas by involving MCP-1, regulated by PI3K/AKT/mTOR and Erk signal pathways.


Sign in / Sign up

Export Citation Format

Share Document